Nectar Lifesciences Ltd.
|
Cash Flow
|
|
You can view the
Cash Flow
for the last 5 years.
Market Cap. (Rs.)
|
676.15 Cr.
|
P/BV
|
0.64
|
Book Value (Rs.)
|
47.47
|
52 Week High/Low (Rs.)
|
46/15
|
FV/ML
|
1/1
|
P/E(X)
|
0.00
|
Bookclosure
|
21/09/2023
|
EPS (Rs.)
|
0.00
|
Div Yield (%)
|
0.00
|
|
(Rs. in Crs.)
Months | 12 | 12 | 12 | 12 | 12 |
Source Of Info (AR = Annual Report, PR = Press Release) | AR | AR | AR | AR | AR |
FaceValue | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 |
| | | | | |
Net Profit/Loss Before Extraordinary Items And Tax | -42.42 | 34.08 | -59.45 | 37.47 | 58.82 |
| | | | | |
Net CashFlow From Operating Activities | 133.65 | 95.01 | 21.38 | 284.96 | 239.24 |
Net Cash Used In Investing Activities | 51.70 | 16.64 | -28.62 | -33.13 | -26.13 |
Net Cash Used From Financing Activities | -185.58 | -119.38 | 11.49 | -251.87 | -201.09 |
| | | | | |
Net Inc/Dec In Cash And Cash Equivalents | -0.23 | -7.73 | 4.25 | -0.03 | 12.02 |
Cash And Cash Equivalents Begin of Year | 17.81 | 25.54 | 21.29 | 21.33 | 9.31 |
Cash And Cash Equivalents End Of Year | 17.58 | 17.81 | 25.54 | 21.29 | 21.33 |